| Home | Article Database | Resources | Tools & Just for Fun | Search HY |

Diabetes Overview

Almost every one of us knows someone who has diabetes. An estimated 16 million people in the United States have diabetes mellitus-a serious, lifelong condition. About half of these people do not know they have diabetes and are not under care for the disorder. Each year, about 650,000 people are diagnosed with diabetes.

Although diabetes occurs most often in older adults, it is one of the most common chronic disorders in children in the United States. About 127,000 children and teenagers age 19 and younger have diabetes.

What Is Diabetes?

Diabetes is a disorder of metabolism--the way our bodies use digested food for growth and energy. Most of the food we eat is broken down by the digestive juices into a simple sugar called glucose. Glucose is the main source of fuel for the body.

After digestion, the glucose passes into our bloodstream where it is available for body cells to use for growth and energy. For the glucose to get into the cells, insulin must be present. Insulin is a hormone produced by the pancreas, a large gland behind the stomach.

When we eat, the pancreas is supposed to automatically produce the right amount of insulin to move the glucose from our blood into our cells. In people with diabetes, however, the pancreas either produces little or no insulin, or the body cells do not respond to the insulin that is produced. As a result, glucose builds up in the blood, overflows into the urine, and passes out of the body. Thus, the body loses its main source of fuel even though the blood contains large amounts of glucose.

What Are the Different Types of Diabetes?

The three main types of diabetes are:

  • Insulin-dependent diabetes mellitus (IDDM) or Type I diabetes
  • Noninsulin-dependent diabetes mellitus (NIDDM) or Type II diabetes
  • Gestational diabetes.

Insulin-Dependent Diabetes
Insulin-dependent diabetes is considered an autoimmune disease. An autoimmune disease results when the body's system for fighting infection (the immune system) turns against a part of the body. In diabetes, the immune system attacks the insulin-producing beta cells in the pancreas and destroys them. The pancreas then produces little or no insulin.

Someone with IDDM needs daily injections of insulin to live. At present, scientists do not know exactly what causes the body's immune system to attack the beta cells, but they believe that both genetic factors and viruses are involved. IDDM accounts for about 5 to 10 percent of diagnosed diabetes in the United States.

IDDM develops most often in children and young adults, but the disorder can appear at any age. Symptoms of IDDM usually develop over a short period, although beta cell destruction can begin months, even years, earlier.

Symptoms include increased thirst and urination, constant hunger, weight loss, blurred vision, and extreme tiredness. If not diagnosed and treated with insulin, a person can lapse into a life-threatening coma.

Noninsulin-Dependent Diabetes
The most common form of diabetes is noninsulin-dependent diabetes. About 90 to 95 percent of people with diabetes have NIDDM. This form of diabetes usually develops in adults over the age of 40 and is most common among adults over age 55. About 80 percent of people with NIDDM are overweight.

In NIDDM, the pancreas usually produces insulin, but for some reason, the body cannot use the insulin effectively. The end result is the same as for IDDM-an unhealthy buildup of glucose in the blood and an inability of the body to make efficient use of its main source of fuel.

The symptoms of NIDDM develop gradually and are not as noticeable as in IDDM. Symptoms include feeling tired or ill, frequent urination (especially at night), unusual thirst, weight loss, blurred vision, frequent infections, and slow healing of sores.

Gestational Diabetes
Gestational diabetes develops or is discovered during pregnancy. This type usually disappears when the pregnancy is over, but women who have had gestational diabetes have a greater risk of developing NIDDM later in their lives.

What Is the Scope and Impact of Diabetes?

Diabetes is widely recognized as one of the leading causes of death and disability in the United States. According to death certificate data, diabetes contributed to the deaths of more than 169,000 persons in 1992.

Diabetes is associated with long-term complications that affect almost every major part of the body. It contributes to blindness, heart disease, strokes, kidney failure, amputations, and nerve damage. Uncontrolled diabetes can complicate pregnancy, and birth defects are more common in babies born to women with diabetes.

Diabetes cost the United States $92 billion in 1992. Indirect costs, including disability payments, time lost from work, and premature death, totaled $47 billion; medical costs for diabetes care, including hospitalizations, medical care, and treatment supplies, totaled $45 billion.

Who Gets Diabetes?

Diabetes is not contagious. People cannot "catch" it from each other. However, certain factors can increase one's risk of developing diabetes. People who have family members with diabetes (especially NIDDM), who are overweight, or who are African American, Hispanic, or Native American are all at greater risk of developing diabetes.

IDDM occurs equally among males and females, but is more common in whites than in nonwhites. Data from the World Health Organization's Multinational Project for Childhood Diabetes indicate that IDDM is rare in most Asian, African, and Native American populations. On the other hand, some northern European countries, including Finland and Sweden, have high rates of IDDM. The reasons for these differences are not known.

NIDDM is more common in older people, especially older women who are overweight, and occurs more often among African Americans, Hispanics, and Native Americans. Compared with non-Hispanic whites, diabetes rates are about 60 percent higher in African Americans and 110 to 120 percent higher in Mexican Americans and Puerto Ricans. Native Americans have the highest rates of diabetes in the world. Among Pima Indians living in the United States, for example, half of all adults have NIDDM. The prevalence of diabetes is likely to increase because older people, Hispanics, and other minority groups make up the fastest growing segments of the U.S. population.

How Is Diabetes Managed?

Before the discovery of insulin in 1921, all people with IDDM died within a few years after the appearance of the disease. Although insulin is not considered a cure for diabetes, its discovery was the first major breakthrough in diabetes treatment.

Today, daily injections of insulin are the basic therapy for IDDM. Insulin injections must be balanced with meals and daily activities, and glucose levels must be closely monitored through frequent blood sugar testing.

Diet, exercise, and blood testing for glucose are also the basis for management of NIDDM. In addition, some people with NIDDM take oral drugs or insulin to lower their blood glucose levels.

People with diabetes must take responsibility for their day-to-day care. Much of the daily care involves trying to keep blood sugar levels from going too low or too high. When blood sugar levels drop too low--a condition known as hypoglycemia--a person can become nervous, shaky, and confused. Judgment can be impaired. Eventually, the person could pass out. The treatment for low blood sugar is to eat or drink something with sugar in it.

On the other hand, a person can become very ill if blood sugar levels rise too high, a condition known as hyperglycemia. Hypoglycemia and hyperglycemia, which can occur in people with IDDM or NIDDM, are both potentially life-threatening emergencies.

People with diabetes should be treated by a doctor who monitors their diabetes control and checks for complications. Doctors who specialize in diabetes are called endocrinologists or diabetologists. In addition, people with diabetes often see ophthalmologists for eye examinations, podiatrists for routine foot care, dietitians for help in planning meals, and diabetes educators for instruction in day-to-day care.

The goal of diabetes management is to keep blood glucose levels as close to the normal (nondiabetic) range as safely possible. A recent Government study, sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), proved that keeping blood sugar levels as close to normal as safely possible reduces the risk of developing major complications of diabetes.

The 10-year study, called the Diabetes Control and Complications Trial (DCCT), was completed in 1993 and included 1,441 people with IDDM. The study compared the effect of two treatment approaches--intensive management and standard management--on the development and progression of eye, kidney, and nerve complications of diabetes. Researchers found that study participants who maintained lower levels of blood glucose through intensive management had significantly lower rates of these complications.

Researchers believe that DCCT findings have important implications for the treatment of NIDDM, as well as IDDM.

What Is the Status of Diabetes Research?

NIDDK supports basic and clinical research in its own laboratories and in research centers and hospitals throughout the United States. It also gathers and analyzes statistics about diabetes. Other institutes at the National Institutes of Health also carry out research on diabetes-related eye diseases, heart and vascular complications, pregnancy, and dental problems.

Other Government agencies that sponsor diabetes programs are the Centers for Disease Control and Prevention, the Indian Health Service, the Health Resources and Services Administration, the Bureau of Veterans Affairs, and the Department of Defense.

Many organizations outside of the Government support diabetes research and education activities. These organizations include the American Diabetes Association, the Juvenile Diabetes Foundation International, and the American Association of Diabetes Educators.

In recent years, advances in diabetes research have led to better ways to manage diabetes and treat its complications. Major advances include:

  • New forms of purified insulin, such as human insulin produced through genetic engineering

  • Better ways for doctors to monitor blood glucose levels and for people with diabetes to test their own blood glucose levels at home

  • Development of external and implantable insulin pumps that deliver appropriate amounts of insulin, replacing daily injections

  • Laser treatment for diabetic eye disease, reducing the risk of blindness

  • Successful transplantation of kidneys in people whose own kidneys fail because of diabetes

  • Better ways of managing diabetic pregnancies, improving chances of successful outcomes

  • New drugs to treat NIDDM and better ways to manage this form of diabetes through weight control

  • Evidence that intensive management of blood glucose reduces and may prevent development of microvascular complications of diabetes

  • Demonstration that antihypertensive drugs called ACE-inhibitors prevent or delay kidney failure in people with diabetes.

What Will the Future Bring?

In the future, it may be possible to administer insulin through nasal sprays or in the form of a pill or patch. Devices that can "read" blood glucose levels without having to prick a finger to get a blood sample are also being developed.

Researchers continue to search for the cause or causes of diabetes and ways to prevent and cure the disorder. Scientists are looking for genes that may be involved in NIDDM and IDDM. Some genetic markers for IDDM have been identified, and it is now possible to screen relatives of people with IDDM to see if they are at risk for diabetes.

The new Diabetes Prevention Trial-Type I, sponsored by NIDDK, identifies relatives at risk for developing IDDM and treats them with low doses of insulin or with oral insulin-like agents in the hope of preventing IDDM. Similar research is carried out at other medical centers throughout the world.

Transplantation of the pancreas or insulin-producing beta cells offers the best hope of cure for people with IDDM. Some pancreas transplants have been successful. However, people who have transplants must take powerful drugs to prevent rejection of the transplanted organ. These drugs are costly and may eventually cause serious health problems.

Scientists are working to develop less harmful drugs and better methods of transplanting pancreatic tissue to prevent rejection by the body. Using techniques of bioengineering, researchers are also trying to create artificial islet cells that secrete insulin in response to increased sugar levels in the blood.

For NIDDM, the focus is on ways to prevent diabetes. Preventive approaches include identifying people at high risk for the disorder and encouraging them to lose weight, exercise more, and follow a healthy diet. The Diabetes Prevention Program, another new NIDDK project, will focus on preventing the disorder in high-risk populations.

Where Is More Information Available?

For more information about IDDM, NIDDM, and gestational diabetes, as well as diabetes research, statistics, and education, contact:

National Diabetes Information Clearinghouse
1 Information Way
Bethesda, MD 20892-3560
(301) 654-3327.

The following organizations also distribute materials and support programs for people with diabetes and their families and friends:

American Association of Diabetes Educators
444 North Michigan Avenue, Suite 1240
Chicago, IL 60611
(800) 832-6874
(312) 644-2233

American Diabetes Association
ADA National Service Center
1660 Duke Street
Alexandria, VA 22314
(800) 232-3472
(703) 549-1500

Juvenile Diabetes Foundation International
120 Wall Street
19th Floor
New York, NY 10005
(800) 223-1138
(212) 785-9500.

Points to Remember

What Is Diabetes
  • A disorder of metabolism--the way the body digests food for energy and growth.
What Are the Different Types of Diabetes?
  • Insulin-dependent diabetes (IDDM)
  • Noninsulin-dependent diabetes (NIDDM)
  • Gestational diabetes.
What Is the Scope and Impact of Diabetes?
  • Affects 16 million people
  • A leading cause of death and disability
  • Costs $92 billion per year.
Who Gets Diabetes?
  • People of any age
  • More common in older people, African Americans, Hispanics, and Native Americans.

National Diabetes Information Clearinghouse
1 Information Way
Bethesda, MD 20892-3560
ndic@aerie.com

The National Diabetes Information Clearinghouse (NDIC) is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health, under the U.S. Public Health Service. The clearinghouse, authorized by Congress in 1978, provides information about diabetes to people with diabetes and their families, health care professionals, and the public. NDIC answers inquiries; develops, reviews, and distributes publications; and works closely with professional and patient organizations and government agencies to coordinate resources about diabetes.

Publications produced by the clearinghouse are reviewed carefully for scientific accuracy, content, and readability. Materials produced by other sources are also reviewed for scientific accuracy and are used, along with clearinghouse publications, to answer inquiries.

This epub is not subject to copyright restrictions. The clearinghouse encourages users of this etext to duplicate and distribute as many copies as desired.


NIH Publication No. 96-3873
October 1995
Etext last updated: 6 August 1996